Community Guide
Peptides for Hair Loss and Hair Growth
Hair loss accounts occupy a distinct corner of the peptide community: empirical, incremental, and rarely satisfied with a single compound. The confessions here are not about miracle regrowth. They are about adding tools the mainstream options don't cover — scalp environment, follicle health, collagen support, and circulation — on top of an established foundation. GHK-Cu is the most cited compound in community hair accounts, followed by PTD-DBM, BPC-157, and a smaller subset of follistatin and thymosin beta-4 accounts.
GHK-Cu: What the Community Actually Reports
GHK-Cu (copper peptide) is the dominant hair compound in community accounts by volume. Accounts describe two delivery routes: topical application (serums, scalp drops, mixed into minoxidil) and subcutaneous scalp injection. Topical accounts report reduced shedding within 4–8 weeks, improved hair texture, and visible density changes at 3–6 months of consistent use. Injectable accounts describe similar timelines with reports of more localised, concentrated effects at injection sites. The community consensus: GHK-Cu works on the follicle environment — improving scalp vascularity, collagen support, and follicle health — rather than blocking DHT. Accounts framing it as a DHT blocker substitute consistently report disappointment. Accounts using it alongside finasteride or minoxidil consistently report additive benefit.
PTD-DBM: The DHT-Pathway Adjunct
PTD-DBM appears in a smaller but consistent subset of community hair accounts, often in combination with GHK-Cu. The framing in accounts is more mechanistically specific than GHK-Cu: PTD-DBM is described as interfering with the CXXC5/Dvl interaction in the Wnt pathway, which plays a role in follicle cycling. Community accounts describe improvement in crown and vertex areas in particular — regions typically associated with androgenic alopecia. Dosing in accounts clusters around 10–50mcg subcutaneous injections to the scalp, 2–3 times per week. Onset timelines in accounts describing results range from 8–16 weeks. PTD-DBM is rarely used as a standalone — the community treats it as a second-layer adjunct to GHK-Cu and the standard finasteride/minoxidil foundation.
BPC-157 and Follistatin in Hair Protocols
BPC-157 appears in hair loss accounts framed around scalp circulation and healing response rather than follicle-level intervention. Accounts describe subcutaneous scalp injections (200–500mcg per injection site) or systemic dosing with reported secondary improvements in scalp health. The mechanism cited in accounts: BPC-157 promotes angiogenesis and tissue repair, improving the vascular supply to follicles. Follistatin accounts are less common and tend to appear in confessions from users with advanced androgenic alopecia who have exhausted standard options. The community framing for follistatin: potential upside through myostatin and activin pathway modulation, but harder to dose, more expensive, and with fewer outcome reports than the other compounds. Neither BPC-157 nor follistatin is a primary recommendation in community hair protocols — they appear as tertiary adjuncts.
The Community's Hair Protocol Framework
The near-universal pattern in community hair confessions: peptides are not the foundation. Finasteride or dutasteride (DHT reduction) and minoxidil (vasodilation, follicle anagen extension) anchor the vast majority of protocols, with peptides layered on top. The most common community stack described in accounts: finasteride daily, minoxidil topically once or twice daily, GHK-Cu serum applied to scalp after minoxidil, and PTD-DBM injections 2–3 times per week to targeted areas. BPC-157 appears as an add-on in accounts where scalp inflammation or poor vascularity is a stated concern. Accounts that rely solely on peptides without the established foundation consistently report inferior outcomes. The community's honest framing: peptides improve the follicle environment and extend what the primary treatments can accomplish — they are amplifiers, not replacements.
Timelines and Realistic Expectations
Community accounts for peptide hair protocols set a consistent expectation: this is a 3–6 month minimum commitment before meaningful evaluation. The hair cycle means that early improvements in follicle health are not visible as regrowth until the follicle cycles — accounts describe reduced shedding first (2–4 weeks), improved hair calibre and texture next (6–10 weeks), and visible density changes last (3–6 months). Accounts describing early regrowth claims should be read with scepticism — the biology does not support rapid regrowth. The most credible accounts describe before-and-after photos taken at 6-month intervals, noting incremental rather than dramatic changes. The consensus: peptide hair protocols require the same patience discipline as the standard treatments, with outcomes in the moderate improvement range rather than the dramatic reversal range.
Related peptides:
Community Q&A
- What is the best peptide for hair loss?
- GHK-Cu is the most consistently reported hair peptide in community accounts, with the best evidence-to-experience ratio of the available options. It improves scalp environment, supports follicle health, and reduces shedding in most accounts that use it consistently for 8+ weeks. PTD-DBM appears as the best adjunct for androgenic alopecia specifically. Neither replaces finasteride or minoxidil — the community treats peptides as complementary layers on an established foundation, not standalone solutions.
- Does GHK-Cu work for hair regrowth?
- Community accounts describe GHK-Cu as producing real but incremental results — meaningful improvement in hair retention and density over 3–6 months, not dramatic regrowth. Topical accounts are the most common, with subcutaneous scalp injections described as more concentrated but not dramatically better in most comparisons. The mechanism cited in accounts: GHK-Cu supports scalp vascularity, collagen structure, and follicle health rather than blocking DHT. It works best combined with a DHT-blocking foundation.
- Can I use peptides instead of finasteride or minoxidil?
- Community accounts consistently say no — and accounts that have tried peptide monotherapy for hair loss generally report disappointing outcomes. Finasteride and minoxidil have the strongest evidence base and the most community-validated protocols. Peptides work as adjuncts that improve what standard treatments can accomplish. The accounts describing the best hair outcomes use peptides on top of the established foundation, not instead of it.
- How do you inject GHK-Cu into the scalp?
- Community accounts describe subcutaneous scalp injections using 30–31g insulin needles, 4–6mm length, injected at multiple sites across the affected area at approximately 1cm spacing. Common doses in accounts: 100–500mcg per injection site, 2–3 times per week. Reconstituted GHK-Cu is drawn into an insulin syringe and injected at a shallow angle. Accounts describe mild stinging and temporary local redness post-injection. The topical route (serum applied after scalp preparation) is more common in accounts due to lower barrier to entry, with injectable accounts reserved for users comfortable with subcutaneous injection technique.